Disclosure Statement Pursuant to the Pink Basic Disclosure Guidelines

VG LIFE SCIENCES INC.

A Delaware Corporation

447 Broadway

2nd Floor, Unit 103 New York, NY 10013 ________________________________ 435-387-5156www.vglscorp.cominfo@vglscorp.com6719

Annual Report

For the Period Ending: December 31, 2021

(the "Reporting Period")

As of December 31, 2021, the number of shares outstanding of our Common Stock was: 2,768,782,721

As of September 30, 2021, the number of shares outstanding of our Common Stock was: 2,083,841,240

As of December 31, 2021, the number of shares outstanding of our Common Stock was: 2,768,782,721

Indicate by check mark whether the company is a shell company (as defined in Rule 405 of the Securities Act of 1933 and Rule 12b-2 of the Exchange Act of 1934):

Yes:

No:

Indicate by check mark whether the company's shell status has changed since the previous reporting period:Yes:

No:

Indicate by check mark whether a Change in Control1 of the company has occurred over this reporting period:

1 "Change in Control" shall mean any events resulting in:

(i) Any "person" (as such term is used in Sections 13(d) and 14(d) of the Exchange Act) becoming the "beneficial owner" (as defined in Rule 13d-3 of the Exchange Act), directly or indirectly, of securities of the Company representing fifty percent (50%) or more of the total voting power represented by the Company's then outstanding voting securities;

  • (ii) The consummation of the sale or disposition by the Company of all or substantially all of the Company's assets;

  • (iii) A change in the composition of the Board occurring within a two (2)-year period, as a result of which fewer than a majority of the directors are directors immediately prior to such change; or

Yes: 1)

No:

Name and address(es) of the issuer and its predecessors (if any)

In answering this item, provide the current name of the issuer any names used by predecessor entities, along with the dates of the name changes.

  • - VG Life Sciences Inc. since November 3, 2012

  • - Viral Genetics, Inc. until November, 2012

  • - 5 Star Living Online, Inc. until November, 2001

  • - HiTech Investment, Inc. until April, 1999

The state of incorporation or registration of the issuer and of each of its predecessors (if any) during the past five years; Please also include the issuer's current standing in its state of incorporation (e.g. active, default, inactive):

- Delaware, June 6, 1998. delinquent

Describe any trading suspension orders issued by the SEC concerning the issuer or its predecessors since inception:

N/A

List any stock split, stock dividend, recapitalization, merger, acquisition, spin-off, or reorganization either currently anticipated or that occurred within the past 12 months:

- Going forward, the Company anticipates it will seek to conduct one or more of the following actions; recapitalization, merger, SEC registration statement, acquisition, reverse merger

The address(es) of the issuer's principal executive office:

The Company's principal place of business is 447 Broadway, 2nd Floor, Unit 103 New York, NY 10013

The address(es) of the issuer's principal place of business:

Check box if principal executive office and principal place of business are the same address:

Has the issuer or any of its predecessors been in bankruptcy, receivership, or any similar proceeding in the past five years?

Yes:

No:

If this issuer or any of its predecessors have been the subject of such proceedings, please provide additional details in the space below:

N/A

(iv) The consummation of a merger or consolidation of the Company with any other corporation, other than a merger or consolidation which would result in the voting securities of the Company outstanding immediately prior thereto continuing to represent (either by remaining outstanding or by being converted into voting securities of the surviving entity or its parent) at least fifty percent (50%) of the total voting power represented by the voting securities of the Company or such surviving entity or its parent outstanding immediately after such merger or consolidation.

2)Security Information

Trading symbol:

VGLS

Exact title and class of securities outstanding:

Common Shares

CUSIP:

91822T101

Par or stated value:

$0.0001

Total shares authorized:

3,000,000,000

as of date: 12/31/2021

Total shares outstanding:

2,768,782,721

as of date: 12/31/2021

Number of shares in the Public Float2:

2,070,220,343

as of date: 12/31/2021

Total number of shareholders of record:

314

as of date: 12/31/2021

All additional class(es) of publicly traded securities (if any):

Trading symbol:

Exact title and class of securities outstanding: CUSIP:

Par or stated value:

Total shares authorized: Total shares outstanding:

Transfer Agent

Name: Liberty Stock Transfer, Inc. Phone: (732) 372-0707

Email: info@@libertystocktransfer.comas of date:as of date:Address: 788 Shrewsbury Ave., Suite 2163, Tinton Falls, NJ 07724

Is the Transfer Agent registered under the Exchange Act? 3 Yes:

No:

3)Issuance History

The goal of this section is to provide disclosure with respect to each event that resulted in any direct changes to the total shares outstanding of any class of the issuer's securities in the past two completed fiscal years and any subsequent interim period.

Disclosure under this item shall include, in chronological order, all offerings and issuances of securities, including debt convertible into equity securities, whether private or public, and all shares, or any other securities or options to acquire such securities, issued for services. Using the tabular format below, please describe these events.

A. Changes to the Number of Outstanding Shares

2 "Public Float" shall mean the total number of unrestricted shares not held directly or indirectly by an officer, director, any person who is the beneficial owner of more than 10 percent of the total shares outstanding (a "control person"), or any affiliates thereof, or any immediate family members of officers, directors and control persons.

3 To be included in the Pink Current Information tier, the transfer agent must be registered under the Exchange Act.

Check this box to indicate there were no changes to the number of outstanding shares within the past two completed fiscal years and any subsequent periods:

Shares Outstanding as of Second Most Recent

Fiscal Year End: 1/01/2020

Opening Balance

Common: 112,283,815 Preferred A: 10,000,000

*Right-click the rows below and select "Insert" to add rows as needed.

Date of Transaction

Transaction type (e.g. new issuance, cancellation, shares returned to treasury)

Number of Shares Issued (or canceled)

Class of Securities

Value of shares issued ($/per share) at Issuance

Were the shares issued at a discount to market price at the time of issuance ? (Yes/No)

Individual/ Entity Shares were issued to (entities must have individual with voting / investment control disclosed).

Reason for share issuance (e.g. for cash or debt conversion) -OR-

Nature of Services Provided

Restricted or Unrestricted as of this filing.

Exemption or Registration Type.

10/30/2020

issuance

11,116,097

CS

.01

Yes

Top Knot, Inc.- John Kellas

debt conversion

Unrestricted

3(a)10

11/18/2020

issuance

11,200,000

CS

.01

Yes

Mark Borden

debt conversion

Unrestricted

3(a)10

11/19/2020

issuance

250,000,000

CS

.0001

Yes

Endicott Holdings Group, LLC Mahmoud Jrab-Managing Member

Services

Restricted

11/20/2020

issuance

28,000,000

CS

.005

Yes

Mark Borden

debt conversion

Unrestricted

3(a)10

11/25/2020

issuance

28,000,000

CS

.005

Yes

Top Knot, Inc.- John Kellas

debt conversion

Unrestricted

3(a)10

12/11/2021

issuance

40,000,000

CS

.005

Yes

Mark Borden

debt conversion

Unrestricted

3(a)10

12/11/2020

issuance

20,000,000

CS

.005

Yes

Top Knot, Inc.- John Kellas

debt conversion

Unrestricted

3(a)10

1/11/2020

issuance

20,000,000

CS

.005

Yes

Intermarket Associates, LLC-Charles Abujudeh

debt conversion

Unrestricted

3(a)10

1/11/2020

issuance

20,000,000

CS

.005

Yes

OC Sparkle, Inc-Abraham Abu

debt conversion

Unrestricted

3(a)10

1/27/2020

issuance

50,000,000

CS

.005

Yes

Intermarket Associates, LLC-Charles Abujudeh

debt conversion

Unrestricted

3(a)10

02/03/2021

issuance

40,000,000

CS

.005

Yes

Top Knot, Inc.-John Kellas

debt conversion

Unrestricted

3(a)10

02/08/2021

Retired

-40,000,000

CS

.005

Yes

Mark Borden

debt conversion

Unrestricted

3(a)10

02/09/2021

issuance

50,000,000

CS

.005

Yes

OC Sparkle, Inc-Abraham Abu

debt conversion

Unrestricted

3(a)10

04/26/2021

issuance

63,419,391

CS

0.00365

Yes

Top Knot, Inc.-John Kellas

debt conversion

Unrestricted

3(a)10

06/29/2021

issuance

40,000,000

CS

.003

Yes

James Bursey

debt conversion

Unrestricted

3(a)10

07/15/2021

issuance

64,000,000

CS

0.0025

Yes

James Bursey

debt conversion

Unrestricted

3(a)10

07/20/2021

issuance

69,597,910

CS

0.003

Yes

MSW Projects Ltd-Bruce Bent

debt conversion

Unrestricted

3(a)10

07/21/2021

issuance

86,800,000

CS

0.003

Yes

James Bursey

debt conversion

Unrestricted

3(a)10

08/04/2021

issuance

95,477,304

CS

0.00275

Yes

James Bursey

debt conversion

Unrestricted

3(a)10

08/05/2021

issuance

104,929,557

CS

0.00275

Yes

MSW Projects Ltd-Bruce Bent

debt conversion

Unrestricted

3(a)10

08/16/2021

issuance

115,317,583

CS

0.0039

Yes

James Bursey

debt conversion

Unrestricted

3(a)10

08/25/2021

issuance

126,734,024

CS

0.0015

Yes

MSW Projects Ltd-Bruce Bent

debt conversion

Unrestricted

3(a)10

08/27/2021

issuance

139,280,692

CS

0.0015

Yes

James Bursey

debt conversion

Unrestricted

3(a)10

09/01/2021

issuance

153,069,481

CS

0.0027

Yes

MSW Projects Ltd-Bruce Bent

debt conversion

Unrestricted

3(a)10

09/20/2021

issuance

384,615,385

CS

0.0026

Yes

Paul Rachmuth

Legal Services Agreement

Restricted

N/A

12/09/2021

issuance

206,300,283

CS

0.0008

Yes

MSW Projects Ltd-Bruce Bent

debt conversion

Unrestricted

3(a)10

12/17/2021

issuance

226,724,011

CS

0.00077

Yes

MSW Projects Ltd-Bruce Bent

debt conversion

Unrestricted

3(a)10

12/23/2021

issuance

2,500,000

CS

0.0014

No

Axiom-Darren Bankston

services

Restricted

N/A

12/30/2021

issuance

249,417,188

CS

0.000565

Yes

Bruce Bent

debt conversion

Unrestricted

3(a)10

Shares Outstanding on December 31, 2021:

This is an excerpt of the original content. To continue reading it, access the original document here.

Attachments

  • Original Link
  • Original Document
  • Permalink

Disclaimer

VG Life Sciences Inc. published this content on 31 March 2022 and is solely responsible for the information contained therein. Distributed by Public, unedited and unaltered, on 31 March 2022 22:27:25 UTC.